BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30301603)

  • 1. Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression.
    Sun Z; Zhou S; Tang J; Ye T; Li J; Liu D; Zhou J; Wang J; Rosie Xing H
    EBioMedicine; 2018 Nov; 37():47-55. PubMed ID: 30301603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A8 transported by SEC23A inhibits metastatic colonization via autocrine activation of autophagy.
    Sun Z; Zeng B; Liu D; Zhao Q; Wang J; Rosie Xing H
    Cell Death Dis; 2020 Aug; 11(8):650. PubMed ID: 32811814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SEC23A Inhibit Melanoma Metastatic through Secretory PF4 Cooperation with SPARC to Inhibit MAPK Signaling Pathway.
    Zeng B; Sun Z; Zhao Q; Liu D; Chen H; Li X; Xing HR; Wang J
    Int J Biol Sci; 2021; 17(12):3000-3012. PubMed ID: 34421345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.
    Liu S; Tetzlaff MT; Cui R; Xu X
    Am J Pathol; 2012 Nov; 181(5):1823-35. PubMed ID: 22982443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.
    Szczyrba J; Nolte E; Wach S; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA
    Mol Cancer Res; 2011 Jun; 9(6):791-800. PubMed ID: 21593139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression" [EBioMedicine 37 (2018) 47-55].
    Sun Z; Zhou S; Tang J; Ye T; Li J; Liu D; Zhou J; Wang J; Xing HR
    EBioMedicine; 2021 Aug; 70():103508. PubMed ID: 34364168
    [No Abstract]   [Full Text] [Related]  

  • 7. MicroRNA expression characterizes oligometastasis(es).
    Lussier YA; Xing HR; Salama JK; Khodarev NN; Huang Y; Zhang Q; Khan SA; Yang X; Hasselle MD; Darga TE; Malik R; Fan H; Perakis S; Filippo M; Corbin K; Lee Y; Posner MC; Chmura SJ; Hellman S; Weichselbaum RR
    PLoS One; 2011; 6(12):e28650. PubMed ID: 22174856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic inhibition of NUDT21 by secretory S100A11 and exosomal miR-487a-5p promotes melanoma oligo- to poly-metastatic progression.
    Zeng B; Chen Y; Chen H; Zhao Q; Sun Z; Liu D; Li X; Zhang Y; Wang J; Xing HR
    Mol Oncol; 2023 Dec; 17(12):2743-2766. PubMed ID: 37356089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time.
    Dhondt B; De Bleser E; Claeys T; Buelens S; Lumen N; Vandesompele J; Beckers A; Fonteyne V; Van der Eecken K; De Bruycker A; Paul J; Gramme P; Ost P
    World J Urol; 2019 Dec; 37(12):2557-2564. PubMed ID: 30578441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.
    Korpal M; Ell BJ; Buffa FM; Ibrahim T; Blanco MA; Celià-Terrassa T; Mercatali L; Khan Z; Goodarzi H; Hua Y; Wei Y; Hu G; Garcia BA; Ragoussis J; Amadori D; Harris AL; Kang Y
    Nat Med; 2011 Aug; 17(9):1101-8. PubMed ID: 21822286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
    Wang Y; Lieberman R; Pan J; Zhang Q; Du M; Zhang P; Nevalainen M; Kohli M; Shenoy NK; Meng H; You M; Wang L
    Mol Cancer; 2016 Nov; 15(1):70. PubMed ID: 27832783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy.
    Bhattacharya A; Schmitz U; Raatz Y; Schönherr M; Kottek T; Schauer M; Franz S; Saalbach A; Anderegg U; Wolkenhauer O; Schadendorf D; Simon JC; Magin T; Vera J; Kunz M
    Oncotarget; 2015 Feb; 6(5):2966-80. PubMed ID: 25650662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of microenvironment: the role of CCL8 in metastasis formation of melanoma.
    Barbai T; Fejős Z; Puskas LG; Tímár J; Rásó E
    Oncotarget; 2015 Oct; 6(30):29111-28. PubMed ID: 26320180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis.
    Berlanga P; Muñoz L; Piqueras M; Sirerol JA; Sánchez-Izquierdo MD; Hervás D; Hernández M; Llavador M; Machado I; Llombart-Bosch A; Cañete A; Castel V; Font de Mora J
    Mol Oncol; 2016 Aug; 10(7):1043-53. PubMed ID: 27155790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulated miR-200c and Nkx2.1 in a nuclear/mitochondria transcriptional regulatory network of non-metastatic and metastatic lung cancer cells.
    D'Almeida O; Mothar O; Bondzie EA; Lieumo Y; Tagne L; Gupta S; Volkert T; Levine S; Tagne JB
    BMC Cancer; 2019 Feb; 19(1):136. PubMed ID: 30744585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-21 promotes proliferation, migration, and invasion of colorectal cancer, and tumor growth associated with down-regulation of sec23a expression.
    Li C; Zhao L; Chen Y; He T; Chen X; Mao J; Li C; Lyu J; Meng QH
    BMC Cancer; 2016 Aug; 16():605. PubMed ID: 27495250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis.
    Lohcharoenkal W; Das Mahapatra K; Pasquali L; Crudden C; Kular L; Akkaya Ulum YZ; Zhang L; Xu Landén N; Girnita L; Jagodic M; Ståhle M; Sonkoly E; Pivarcsi A
    J Invest Dermatol; 2018 Apr; 138(4):882-892. PubMed ID: 29104160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.
    Li Y; Li M; Shats I; Krahn JM; Flake GP; Umbach DM; Li X; Li L
    PLoS One; 2019; 14(6):e0218067. PubMed ID: 31199813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC.
    Pan Y; Lu F; Xiong P; Pan M; Zhang Z; Lin X; Pan M; Huang H
    J Exp Clin Cancer Res; 2018 Jul; 37(1):167. PubMed ID: 30041660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
    Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
    Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.